Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Using sentiment indicators with index level data combines psychology and price to strengthen analysis. This overview provides steps to integrate both streams.
26,603 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
A quiet stake in IonQ has sparked big questions. Is Amazon signaling a sweeping strategic shift in quantum computing,...
Palantir faces a pivotal investor update that could move the stock. This guide breaks down the risks, catalysts, and ...
NIO reports its first-ever quarterly profit, but shares fall while Tesla leads a modest rally, illustrating the two-s...
A rapid shift is redefining tech leadership along a coastal corridor from NYC to Miami. The next great american tech ...
Investors are buzzing as SAIC reports stronger-than-expected results and a growing federal pipeline. This article bre...
Rocket Lab stands as the only public space stock with a direct line to actual launches and defense demand, even as Sp...
CrowdStrike has become a pillar in AI-era cybersecurity, but a 14% decline raises the question: is it a buy? This gui...
U.S. stocks fell sharply as fears of broader conflict intensified. The S&P 500 dropped about 1% in early trading, wit...
Ethereum is shaping a decisive move as the 4-hour chart tightens into a triangle. A breakout above the upper line cou...
A tech founder explains why he dismissed roughly 80% of his team after AI resistance and what it means for workers an...
A major enterprise contract could transform D-Wave from a hardware play into a recurring-revenue champion. This artic...